Notice Of Verification Of Exclusivity And Uniqueness Of The Supply. Purchase Of N. 1 (One) Illumina Nextseq2000 Sequencing Platform, Based On Sequencing By Synthesis ("Sbs") Technology, For The Research Needs Of The Department Of Medicine And Surgery.

Universita di Parma Italy has Released a tender for Notice Of Verification Of Exclusivity And Uniqueness Of The Supply. Purchase Of N. 1 (One) Illumina Nextseq2000 Sequencing Platform, Based On Sequencing By Synthesis ("Sbs") Technology, For The Research Needs Of The Department Of Medicine And Surgery. in Pharmaceuticals. The tender was released on Sep 16, 2024.

Country - Italy

Summary - Notice Of Verification Of Exclusivity And Uniqueness Of The Supply. Purchase Of N. 1 (One) Illumina Nextseq2000 Sequencing Platform, Based On Sequencing By Synthesis ("Sbs") Technology, For The Research Needs Of The Department Of Medicine And Surgery.

Deadline - login to view

MT reference number - 93350845

Product classification - Research, testing and scientific technical simulator

Organization Details:

  Address - Italy

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 93350845

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: The Department of Medicine and Surgery has identified, following its own investigation of the reference market, an Illumina NextSeq2000 Sequencing Platform, produced and marketed solely and exclusively by Illumina Italy S.r.l., as a tool that has the characteristics suitable for achieving the objectives of the specific research. This notice intends to verify the exclusivity and uniqueness of the supply and the existence or otherwise on the market of other products with similar or superior characteristics and at equal or better economic conditions than that offered by the company Illumina Italy. Main characteristics of the Illumina NextSeq2000 sequencing platform, based on Sequen

Mt Ref Id - 93350845

Deadline - Nov 30, -0001

Share

Similar Tenders :